Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia

Leuk Lymphoma. 2019 Nov;60(11):2838-2840. doi: 10.1080/10428194.2019.1607325. Epub 2019 May 3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / genetics*
  • Combined Modality Therapy
  • Hematopoietic Stem Cell Transplantation / methods*
  • High-Throughput Nucleotide Sequencing / methods*
  • Humans
  • Neoplasm, Residual / diagnosis*
  • Neoplasm, Residual / genetics
  • Polymerase Chain Reaction / methods*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Prognosis

Substances

  • Biomarkers, Tumor